Trial Details
COMPLETEDBasic Information
| Clinical ID | c326 |
|---|---|
| Identifier | NCT03885713 |
| Trial Title | Identification of Predictive Biomarkers for Response to Biologic Therapies and Tofacitinib in Inflammatory Bowel Disease |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Inflammatory Bowel Diseases|Crohn Disease|Ulcerative Colitis |
| Interventions | BIOLOGICAL: Infliximab or adalimumab or golimumab or vedolizumab or ustekinumab or tofacitinib |
Participant Information
| Sponsor | Fundación de Investigación Biomédica - Hospital Universitario de La Princesa |
|---|---|
| City | Oviedo |
| Country/Region | Spain |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE4 |
Time Information
| Start Date | 2019-09-10 |
|---|---|
| Primary Completion Date | 2024-12-31 |
| Completion Date | 2024-12-31 |